Terms: = Lung cancer AND AKT2, PKBBETA, 208, ENSG00000105221, RAC-BETA, P31751, PRKBB AND Prognosis
78 results:
1. Incidence, Correlates, and Prognostic Significance of Mixed Response in Advanced Non-small Cell lung cancer.
Gerber DE; Wang Y; Ramalingam SS; Bhalla S; Sun Z; Borghaei H; Brahmer JR; Schiller JH
Oncologist; 2024 Apr; 29(4):342-349. PubMed ID: 38207008
[TBL] [Abstract] [Full Text] [Related]
2. What is an "early palliative care" intervention? A scoping review of controlled studies in oncology.
Nadolny S; Schildmann E; Gaßmann ES; Schildmann J
Cancer Med; 2023 Dec; 12(23):21335-21353. PubMed ID: 37902232
[TBL] [Abstract] [Full Text] [Related]
3. NSCLC patients with a changing T grade after operation may represent a special subset of tumor staging.
Feng KP; Fu K; Xu C; Ding C; Zhu XY; Pan B; Jia XY; Zhao J; Li C
J Cancer Res Clin Oncol; 2023 Sep; 149(12):9991-9998. PubMed ID: 37258719
[TBL] [Abstract] [Full Text] [Related]
4. Identification and validation of molecular subtype and prognostic signature for lung adenocarcinoma based on neutrophil extracellular traps.
Zuo Y; Leng G; Leng P
Pathol Oncol Res; 2023; 29():1610899. PubMed ID: 37143472
[No Abstract] [Full Text] [Related]
5. prognosis prediction of icotinib as targeted therapy for advanced EGFR-positive non-small cell lung cancer patients.
Tan X; Wang S; Xia H; Chen H; Xu J; Meng D; Wang Z; Li Y; Yang L; Jin Y
Invest New Drugs; 2023 Jun; 41(3):463-472. PubMed ID: 37140694
[TBL] [Abstract] [Full Text] [Related]
6. RANKL acts an unfavorable prognostic biomarker and potential target in advanced KRAS-mutated lung adenocarcinoma.
Li HS; Liu CM; Wang Y
Thorac Cancer; 2023 May; 14(15):1368-1382. PubMed ID: 37021520
[TBL] [Abstract] [Full Text] [Related]
7. The Impact of Sarcopenia Onset Prior to cancer Diagnosis on cancer Survival: A National Population-Based Cohort Study Using Propensity Score Matching.
Su CH; Chen WM; Chen MC; Shia BC; Wu SY
Nutrients; 2023 Mar; 15(5):. PubMed ID: 36904245
[TBL] [Abstract] [Full Text] [Related]
8. [Retrospective analysis and a cross-sectional questionnaire survey of lung cancer concomitant with interstitial lung disease].
Liu XN; Li J; Chen RX; Shao C; Huang H; Xu X; Zhang MZ; Wang ZJ; Xu Z
Zhonghua Jie He He Hu Xi Za Zhi; 2022 Dec; 45(12):1192-1198. PubMed ID: 36480849
[No Abstract] [Full Text] [Related]
9. Clinical outcomes of curative surgical resection of peritoneal metastasis in patients with colorectal cancer: A long-term follow-up study.
Bang K; Kim JE; Kim TW; Kim SY; Lim SB; Park IJ; Kim CW; Yoon YS; Hong YS
Cancer Med; 2023 Feb; 12(3):2861-2868. PubMed ID: 36069152
[TBL] [Abstract] [Full Text] [Related]
10. MET overexpression in EGFR L858R mutant treatment-naïve advanced lung adenocarcinoma correlated with poor prognosis: a real-world retrospective study.
Wang N; Zhu Y; Wu Y; Huang B; Wu J; Zhang R; Fan J; Nie X
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3219-3228. PubMed ID: 35904603
[TBL] [Abstract] [Full Text] [Related]
11. The expression and prognostic significance of PIK3CB in lung adenocarcinoma.
Che N; Zhao N; Zhao X; Su S; Zhang Y; Bai X; Li F; Zhang D; Li Y
Ann Diagn Pathol; 2022 Oct; 60():152001. PubMed ID: 35780638
[TBL] [Abstract] [Full Text] [Related]
12. prognosis of Patients with Bronchopulmonary Neuroendocrine Neoplasms in a Tertiary Neuroendocrine Tumor Centre of Excellence.
Rewitz KS; Grønbæk H; Tabaksblat EM; Dahl Baunwall SM; Dam G
Neuroendocrinology; 2022; 112(12):1214-1224. PubMed ID: 35671706
[TBL] [Abstract] [Full Text] [Related]
13. Regulatory roles of osteopontin in human lung cancer cell epithelial-to-mesenchymal transitions and responses.
Shi L; Hou J; Wang L; Fu H; Zhang Y; Song Y; Wang X
Clin Transl Med; 2021 Jul; 11(7):e486. PubMed ID: 34323425
[TBL] [Abstract] [Full Text] [Related]
14. Evaluation of clinical value and potential mechanism of MTFR2 in lung adenocarcinoma via bioinformatics.
Chen C; Tang Y; Qu WD; Han X; Zuo JB; Cai QY; Xu G; Song YX; Ke XX
BMC Cancer; 2021 May; 21(1):619. PubMed ID: 34039308
[TBL] [Abstract] [Full Text] [Related]
15. [The Strategy and Outcome of Three-port Thoracoscopic Surgery for Synchronous and Metachronous Multiple lung cancer].
Kikunaga S; Fujimori S; Suzuki S; Nagano M; Ohtsuka R; Hamada Y
Kyobu Geka; 2021 Jan; 74(1):33-39. PubMed ID: 33550317
[TBL] [Abstract] [Full Text] [Related]
16. Immunotherapy in advanced Non-Small Cell lung cancer patients with poor performance status: The role of clinical-pathological variables and inflammatory biomarkers.
Lobefaro R; Viscardi G; Di Liello R; Massa G; Iacovino ML; Sparano F; Della Corte CM; Ferrara R; Signorelli D; Proto C; Prelaj A; Galli G; De Toma A; Brambilla M; Ganzinelli M; Trevisan B; Ciardiello F; De Braud F; Morgillo F; Garassino MC; Lo Russo G
Lung Cancer; 2021 Feb; 152():165-173. PubMed ID: 33421923
[TBL] [Abstract] [Full Text] [Related]
17. PTEN, ATM, IDH1 mutations and MAPK pathway activation as modulators of PFS and OS in patients treated by first line EGFR TKI, an ancillary study of the French Cooperative Thoracic Intergroup (IFCT) Biomarkers France project.
Blons H; Oudart JB; Merlio JP; Debieuvre D; de Fraipont F; Audigier-Valette C; Escande F; Hominal S; Bringuier PP; Fraboulet-Moreau S; Ouafik L; Moro-Sibilot D; Lemoine A; Langlais A; Missy P; Morin F; Souquet PJ; Barlesi F; Cadranel J; Beau-Faller M;
Lung Cancer; 2021 Jan; 151():69-75. PubMed ID: 33248711
[TBL] [Abstract] [Full Text] [Related]
18. Establishing a predicted model to evaluate prognosis for initially diagnosed metastatic Her2-positive breast cancer patients and exploring the benefit from local surgery.
Lin H; Wu Y; Liang G; Chen L
PLoS One; 2020; 15(11):e0242155. PubMed ID: 33170907
[TBL] [Abstract] [Full Text] [Related]
19. Weight loss over time and survival: a landmark analysis of 1000+ prospectively treated and monitored lung cancer patients.
Le-Rademacher J; Lopez C; Wolfe E; Foster NR; Mandrekar SJ; Wang X; Kumar R; Adjei A; Jatoi A
J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1501-1508. PubMed ID: 32940014
[TBL] [Abstract] [Full Text] [Related]
20. akt2 drives cancer progression and is negatively modulated by miR-124 in human lung adenocarcinoma.
Liu T; Zhu J; Du W; Ning W; Zhang Y; Zeng Y; Liu Z; Huang JA
Respir Res; 2020 Sep; 21(1):227. PubMed ID: 32873299
[TBL] [Abstract] [Full Text] [Related]
[Next]
